Human Cord Blood CD56+ NK Cells
1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Natural killer (NK) cells are important immune cells that display both anti-infection and antitumor activities. They are defined as CD56 positive and CD3 negative. CD56 or neural cell adhesion molecule (NCAM) is a pathogen recognition receptor that allows NK cells to initiate cytotoxicity in the immune response. Activated NK cells release immune regulatory cytokines, such as interferon (IFN)-γ and TNFα, and display cytotoxicity. NK cells can recognize MHC class I–deficient hematopoietic cells, enabling them to quickly identify and kill stressed cells in the absence of antibodies and MHC complex.
Why choose Human Cord Blood CD56+ NK Cells from AcceGen?
Human Cord Blood CD56+ NK Cells are derived from human umbilical cord blood mononuclear cells with fully consented donors using AcceGen’s advanced technology. Cells are isolated with immunomagnetic separation and cryopreserved immediately to ensure the best viability. Each vial contains more than 1×10^6 cells in 1ml volume. Human Cord Blood CD56+ NK Cells are quality tested with the expression of cell marker CD56.
Species | Human |
Cat.No | ABC-TC3378 |
Quality Control | All cell lots test negative for HIV-1, HBV, HCV, mycoplasma, yeast, fungi, and other pathogens. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | NK Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Cord Blood |
Disease | Normal |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Immune Cells |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
For research use only
Human Cord Blood CD56+ NK Cells provide an ideal cell source for studying the physiology and cellular properties of NK cells in vitro. They can be used to co-culture with other immune cells or study the mechanism of NK cell-mediated cytotoxicity. Natural killer cells are potential candidates for NK cell-based therapy in leukemia and malignancy.